(3beta,5alpha,9alpha,14alpha,22E,24R)-3,5,9,14-Tetrahydroxyergosta-7,22-dien-6-one

Metabolite details

Identifier

RLODFSODJNFIMP-BQYQJAHWSA-N

InChI Key

RLODFSODJNFIMP-BQYQJAHWSA-N

IUPAC name

17-[(E)-5,6-dimethylhept-3-en-2-yl]-3,5,9,14-tetrahydroxy-10,13-dimethyl-2,3,4,11,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-6-one

Preferred name

(3beta,5alpha,9alpha,14alpha,22E,24R)-3,5,9,14-Tetrahydroxyergosta-7,22-dien-6-one

INN name

—

Synonym

—

ChEBI

CHEBI:173235

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Hfq Regulates Efflux Pump Expression and Purine Metabolic Pathway to Increase the Trimethoprim Resistance in Aeromonas veronii
• Metabolic Dynamics of In Vitro CD8+ T Cell Activation.
• Effects of Radiofrequency Field from 5G Communications on fecal microbiome and metabolome profiles in mice
• Intergenerational Association of Gut Microbiota and Metabolism between Perinatal Folic Acid Metabolism and Neural Tube Defects (Feces metabolomics)
• Interaction between Cervical Microbiota and Host Gene Regulation in Caesarean Section Scar Diverticulum
• Mechanism of interventional effect and targets of Zhuyu Pill in regulating and suppressing colitis and cholestasis

Observed in differential profiles

• Wild_type_vs_hfq
• G3_Experimental_Sample_0h_vs_G11_Experimental_Sample_96h
• Sham_vs_Radiofrequency
• Normal_vs_Neural_Tube_Defect
• Control_vs_CSD
• Control_vs_ZYP_High_Dose